Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005

Authors:

Abstract
Treatment of chronic heart failure has evolved substantially during the past 2 decades. By the early 1990s, clinical trials1-3 demonstrated that the use of angiotensin-converting enzyme inhibitors lowered hospitalization rates and conferred a survival benefit in patients with reduced left ventricular function. Similarly, the survival benefit of β-blocker use in patients with reduced left ventricular function was established by the late 1990s.4-6 Since then, numerous efforts have been undertaken to improve quality of care and outcomes for patients with heart failure, including national initiatives sponsored by the Centers for Medicare and Medicaid Services, the Joint Commission, the American Heart Association, and the American College of Cardiology. In general, these efforts have focused on the optimal use of evidence-based pharmacotherapies, lifestyle modifications, and the management of coexisting illnesses.

This publication has 34 references indexed in Scilit: